COVID Summary
What is the death rate for people
COVID Summary
What is the death rate for people hospitalized with COVID-19? 28%
What is the survival rate for people hospitalized with COVID-19? 72%
What rate of hospitalized COVID-19 patients go into the intensive care unit (ICU)? 26%
What percentage of COVID-19 patients who go into the ICU die? 78%
What percentage of COVID-19 patients who go into the ICU survive? 22%
How many days from onset of first symptoms of COVID-19 until ICU admission? 12 days (median)
What is the median length of stay in ICU for COVID-19 patients? 8 day (median)
How many days is the median hospital stay for COVID-19 patients? 11 days
How long does it take from the first COVID-19 symptoms until hospital discharge? 22 days (median)
How long is viral shedding in COVID-19 patients, starting from the first day of symptoms? Until death or in survivors it is 20 days (median)
What is the average age of a hospitalized COVID-19 survivor? 52 years old
What is the average age of a hospitalized COVID-19 who dies? 69 years old
How many days from first COVID-19 symptoms until death for hospitalized patients? 18.5 days
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...
Continue Reading
Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....
Continue Reading
Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...
Continue Reading
BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...
Continue Reading
Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...
Continue Reading